Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01302743 · ClinicalTrials.gov registry record · NA
Cinnamon Bark, Water-Soluble Cinnamon Extract, and Metformin for Treatment of Type 2 DM.
A NA study, sponsored by Mike O'Callaghan Military Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT01302743 is a NA study that was terminated before completion, run by Mike O'Callaghan Military Hospital. The registered enrollment target is 25 participants.
The verdict
NCT01302743, a NA study, was terminated before completion, sponsored by Mike O'Callaghan Military Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to assess whether Cinnamon bark or water-soluble cinnamon is an effective nutraceutical for the initial treatment of diabetes when compared to standard therapy of Metformin.
Interventions
- DRUG Group 1: Metformin
- DIETARY_SUPPLEMENT Group 2: Cinnamon Bark
- DIETARY_SUPPLEMENT Group 3: Cinnulin PF
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2010-11 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01302743
The ClinicalTrials.gov registry entry for NCT01302743 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mike O'Callaghan Military Hospital, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Group 1: Metformin is the first listed.
NCT01302743 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01302743 about?
NCT01302743 is a clinical study titled "Cinnamon Bark, Water-Soluble Cinnamon Extract, and Metformin for Treatment of Type 2 DM.". The purpose of this study is to assess whether Cinnamon bark or water-soluble cinnamon is an effective nutraceutical for the initial treatment of diabetes when compared to standard therapy of Metformin.
What is the current status of trial NCT01302743?
This trial is currently terminated. It is a NA study. The enrollment target is 25 participants. The study started on 2010-11. Estimated completion is 2016-12.
What interventions are being tested in trial NCT01302743?
The interventions under investigation include: Group 1: Metformin (DRUG), Group 2: Cinnamon Bark (DIETARY_SUPPLEMENT), Group 3: Cinnulin PF (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01302743?
This trial is sponsored by Mike O'Callaghan Military Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.